High frequency of circulating HBcAg-specific CD8 T cells in hepatitis B infection: A flow cytometric analysis

Clinical and Experimental Immunology

Volumn 124, Issue 3, 2001, Pages 435-444

  Matsumura, S ^a   Yamamoto, K ^a   Shimada, N ^a   Okano, N ^a   Okamoto, R ^a   Suzuki, T ^a   Hakoda, T ^a   Mizuno, M ^a   Higashi, T ^a   Tsuji, T ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Flow cytometry; Hepatitis B core antigen; Hepatitis B virus; Immune response intracytoplasmic cytokine; T cell

Indexed keywords

CD8 ANTIGEN; HEPATITIS B CORE ANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HELPER CELL; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; REPRODUCIBILITY OF RESULTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034922828     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01561.x     Document Type: Article

References (27)

1. The hepatitis B virus
2. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22, 707 men in Taiwan
3. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen
4. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection
5. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion
6. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B
7. Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatits B
8. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry
9. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies
10. Detection of intracellular cytokines by flow cytometry
11. Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy
12. Determination of antigen-specific memory/effector CD4+ T Cell frequencies by flow cytometry
13. Hepatitis B virus core antigen: Synthesis in Escherichia coli and application in diagnosis
14. Heterogeneity of biological responses of melanoma-specific CTL
15. Efficient major histochompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages
16. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells
17. Hepatitis B virus persistence after recovery from acute viral hepatitis
18. Long-lasting memory T cell responses following self-limited acute hepatitis B
19. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies
20. Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies
21. Serological evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft
22. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B. A major factor in activation of the host immune response to the hepatitis B virus
23. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice
24. Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection
25. Low responsiveness of hepatitis B virus-transgenic mice in antibody response to T-cell-dependent antigen: Defect in antigen-presenting activity of dendritic cell
26. Specific vaccine therapy in chronic hepatitis B. Induction of T cell proliferative responses specific for envelope antigens
27. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice